<
Integen Group will control Wenzhou pharmaceutical supply and marketing
Release time: 2010-07-21 & nbsp & nbsp & nbsp Source:
    After reaching a strategic cooperation with Zhejiang Community Medical Service Community,Zhejiang Provincial Pharmaceutical Business Leading Enterprise Inte Group (000411) also intends to control Wenzhou Pharmaceutical Supply and Marketing Co., Ltd.,To achieve its strategic goal of becoming the largest medical circulation enterprise in Zhejiang Province。 
Interest Group today announced,July 19, 2010,Company Holding subsidiary Zhejiang Inte Pharmaceutical Co., Ltd. and all shareholders of Wenzhou signed the "Investment Cooperation Framework Agreement": Intellar Pharmaceutical intends to adopt the method of combining capital increase and transfer of equity,Investment Holding 51%of the equity of Wenzhou supply and marketing,But the investment amount has not yet been determined。Specifically,It is Intellar Pharmaceutical in cash,Part of the equity of Wenzhou supply and marketing held by 22 natural person shareholders held by Wenzhou supply and marketing in proportion,Increase capital to Wenzhou at the same time,Finally, the proportion of Inte Pharmaceuticals holds Wenzhou's supply and marketing to 51%。Agreement agreement,After completing this equity cooperation item,Wenzhou Supply and Marketing will be renamed "Wenzhou Inte Pharmaceutical Co., Ltd."; and Intel,The registered capital of Intels in Wenzhou is not less than 20 million yuan。Current,The registered capital of Wenzhou supply and marketing is 5 million yuan。
Interest Group said,Intellar Pharmaceuticals stake sports betting appstake betting appbecame the controlling shareholder of Wenzhou Intels,will allocate through resource allocation、Business integration、Business development、Management improvement,Create Wenzhou Inte as a leading company in the regional pharmaceutical circulation in Wenzhou; and,With mutual benefit and win -win、It is conducive to business expansion、Principles that are conducive to improving efficiency and efficiency,Intellar Pharmaceutical will integrate its existing business in Wenzhou area to Intels in Wenzhou。
The agreement between the two parties,Intellar's Intels' Board will consist of 7 people after the entry of Intellar Pharmaceuticals,Among them, Wenzhou supply and marketing commissioned 3 people,Intelble Pharmaceutical Industry Commander 4 people,The chairman is nominated by Inte Pharmaceutical,Vice Chairman is nominated by Wenzhou supply and marketing,Elected by the board of directors; the first business team of Inte's first business team in Wenzhou 3 years,Among them, the general manager is nominated by Wenzhou supply and marketing,Hired by the board of directors,Executive Deputy President and Chief Financial My stake betting appstake betting appDirector are nominated by Inte Pharmaceutical,Hired by the board of directors。
Interest Group said,This investment is a strategic investment。According to the three -year strategic plan of Intellar Pharmaceutical from 2010 to 2012,A suitable target company in Wenzhou area is one of its key tasks this year。Wenzhou Pharmaceutical Supply and Marketing Co., Ltd. is the second regional pharmaceutical circulation enterprise in Wenzhou,If you successfully complete the investment holding of the supply and marketing of Wenzhou,It can realize resource sharing、complementary advantages、Coordinated integration,The sales scale of Inte Pharmaceuticals increases、Profit and market share in Wenzhou have important strategic and practical significance。
Dante Group Tips,Wenzhou's supply and marketing has a certain business scale and high -quality operating quality,There are many potential competitors that cooperate with them in the industry; because the agreement signed this time is the investment cooperation framework agreement,Not yet signed a formal capital increase agreement and equity transfer agreement,There is an stake online sports bettingunsuccessful risk in this investment。